{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:05:12Z","timestamp":1754154312449,"version":"3.41.2"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the current state of interventional clinical trials in otology and neurotology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design\/methods<\/jats:title><jats:p>Review of registered clinical trials on <jats:uri>ClinicalTrials.gov<\/jats:uri> from January 1st 2019 through May 31st 2025. Interventional trials and those that met keyword criteria for otologic\/neurotologic disorders were included. For each study, key characteristics including trial status, trial phase, study design, participants, intervention type, funding source, and results status were collected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>National database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Though the number of interventional otologic and neurotologic clinical trials has grown over the past 15 years, in the past 5 years, there has been a stagnation of the steady growth seen in the preceding ten. The greatest proportion of trials were focused on hearing loss, utilized devices, were randomized, and were funded by sources other than industry or the government. Compared to 2008\u20132018, trends included a shift towards device and procedural interventions for vestibular disorders and a decrease in device trials and increase in behavioral interventions for tinnitus. Emerging areas include novel pharmacological and gene therapies for hearing loss and vestibular schwannoma, but these areas remain gaps and are promising therapeutic avenues that merit further exploration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Future interval assessments exploring the trends in otologic and neurotologic clinical trials should be performed to identify gaps that offer opportunities for innovation of novel therapies and to monitor the health of the clinical trial environment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1598789","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T05:33:57Z","timestamp":1753335237000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical trials in otology and neurotology: state of the science"],"prefix":"10.3389","volume":"16","author":[{"given":"Lindsay S.","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Sagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantina M.","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599812467004","article-title":"Clinical practice guideline development manual, third edition: a quality-driven approach for translating evidence into action","volume":"148","author":"Rosenfeld","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/archotol.1991.01870140052005","article-title":"Clinical research in otolaryngology journals","volume":"117","author":"Rosenfeld","year":"1991","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.otohns.2007.07.018","article-title":"Randomized controlled trials in otolaryngology journals","volume":"137","author":"Yao","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/0194599814563518","article-title":"Recent randomized controlled trials in otolaryngology","volume":"152","author":"Banglawala","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1177\/0194599813506545","article-title":"An analysis of registered clinical trials in otolaryngology from 2007 to 2010: ClinicalTrials.gov","volume":"149","author":"Witsell","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.joto.2020.11.003","article-title":"Clinical trials in otology: examining trends and framework for prioritization","volume":"16","author":"Altshuler","year":"2021","journal-title":"J Otol"},{"year":"2018","key":"ref7"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3126\/nje.v10i3.31622","article-title":"Impact of COVID-19 on clinical trials and clinical research: a systematic review","volume":"10","author":"Sathian","year":"2020","journal-title":"Nepal J Epidemiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.otc.2018.01.006","article-title":"Global hearing loss prevention","volume":"51","author":"Brown","year":"2018","journal-title":"Otolaryngol Clin N Am"},{"year":"","key":"ref10"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/lary.28511","article-title":"Review of pediatric otolaryngology clinical trials: past trends and future opportunities","volume":"130","author":"Shetty","year":"2020","journal-title":"Laryngoscope"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"E507","DOI":"10.1002\/lary.28404","article-title":"Reporting of clinical trial interventions published in leading otolaryngology-head and neck surgery journals","volume":"130","author":"Torgerson","year":"2020","journal-title":"Laryngoscope"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1097\/MAO.0000000000001427","article-title":"Emerging therapies for sensorineural hearing loss","volume":"38","author":"Crowson","year":"2017","journal-title":"Otol Neurotol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3390\/pharmaceutics15030777","article-title":"Future pharmacotherapy for sensorineural hearing loss by protection and regeneration of auditory hair cells","volume":"15","author":"Matsunaga","year":"2023","journal-title":"Pharmaceutics"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/MAO.0000000000002194","article-title":"Hearing protection, restoration, and regeneration: an overview of emerging therapeutics for inner ear and central hearing disorders","volume":"40","author":"Schilder","year":"2019","journal-title":"Otol Neurotol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1055\/s-0042-1750281","article-title":"Approaches to treat sensorineural hearing loss by hair-cell regeneration: the current state of therapeutic developments and their potential impact on audiological clinical practice","volume":"32","author":"Hinton","year":"2021","journal-title":"J Am Acad Audiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmch.2022.05.001","article-title":"Hearing loss drug discovery and medicinal chemistry: current status, challenges, and opportunities","volume":"61","author":"Cousins","year":"2022","journal-title":"Prog Med Chem"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"867453","DOI":"10.3389\/fnins.2022.867453","article-title":"Inner ear drug delivery for sensorineural hearing loss: current challenges and opportunities","volume":"16","author":"Liu","year":"2022","journal-title":"Front Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e2314763121","DOI":"10.1073\/pnas.2314763121","article-title":"A single dose of AC102 restores hearing in a guinea pig model of noise-induced hearing loss to almost prenoise levels","volume":"121","author":"Rommelspacher","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.7874\/jao.2022.00234","article-title":"Systematic review and Meta-analysis of the application of virtual reality in hearing disorders","volume":"26","author":"Kwak","year":"2022","journal-title":"J Audiol Otol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/bioengineering11020117","article-title":"Leveraging Technology for Vestibular Assessment and Rehabilitation in the operational environment: a scoping review","volume":"11","author":"Hoppes","year":"2024","journal-title":"Bioengineering"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"20805","DOI":"10.1038\/s41598-022-24979-9","article-title":"Application of machine learning in the diagnosis of vestibular disease","volume":"12","author":"Anh","year":"2022","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1288945","DOI":"10.3389\/fresc.2024.1288945","article-title":"Proximal auditory AR rehabilitation: system integration and wellness applications-from hearing support up toward vestibular rehabilitation","volume":"5","author":"Lee","year":"2024","journal-title":"Front Rehabil Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1109\/TNSRE.2023.3312692","article-title":"Research on a new rehabilitation robot for balance disorders","volume":"31","author":"Wu","year":"2023","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599814545325","article-title":"Clinical practice guideline: tinnitus","volume":"151","author":"Tunkel","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/00912174241272674","article-title":"Effectiveness of cognitive behavioral therapy in relieving tinnitus","author":"Bal","year":"2024","journal-title":"Int J Psychiatry Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e634","DOI":"10.1055\/s-0044-1788000","article-title":"The effectiveness of cognitive behavioral therapy versus notched sound therapy in adults with chronic subjective tinnitus and normal hearing","volume":"28","author":"Mekki","year":"2024","journal-title":"Int Arch Otorhinolaryngol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3390\/clinpract14040130","article-title":"Individuals with tinnitus report more positive experiences following internet-based cognitive behavioral therapy","volume":"14","author":"Manchaiah","year":"2024","journal-title":"Clin Pract"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10162-024-00960-3","article-title":"The current state of tinnitus diagnosis and treatment: a multidisciplinary expert perspective","volume":"25","author":"Kleinjung","year":"2024","journal-title":"J Assoc Res Otolaryngol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7874\/jao.2023.00416","article-title":"Recent updates on tinnitus management","volume":"27","author":"Lee","year":"2023","journal-title":"J Audiol Otol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1017\/s0022215100138101","article-title":"Trends in randomized controlled trials in ENT: a 30-year review","volume":"111","author":"Ah-See","year":"1997","journal-title":"J Laryngol Otol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.otohns.2005.11.049","article-title":"Levels of evidence in otolaryngology journals","volume":"134","author":"Wasserman","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1046\/j.1365-2273.1997.00008.x","article-title":"Is there an evidence base for the practice of ENT surgery?","volume":"22","author":"Maran","year":"1997","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"JAMA"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/bmj.325.7358.249","article-title":"Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ","volume":"325","author":"Kjaergard","year":"2002","journal-title":"BMJ"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jama.289.4.454","article-title":"Scope and impact of financial conflicts of interest in biomedical research: a systematic review","volume":"289","author":"Bekelman","year":"2003","journal-title":"JAMA"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"E300","DOI":"10.1002\/lary.25942","article-title":"Characteristics of NIH- and industry-sponsored head and neck cancer clinical trials","volume":"126","author":"Devaiah","year":"2016","journal-title":"Laryngoscope"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1056\/NEJMsb051758","article-title":"Regulating academic-industrial research relationships--solving problems or stifling progress?","volume":"353","author":"Stossel","year":"2005","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","article-title":"The revised CONSORT statement for reporting randomized trials: explanation and elaboration","volume":"134","author":"Altman","year":"2001","journal-title":"Ann Intern Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1200\/JCO.2008.21.1938","article-title":"The transition from phase II to phase III studies","volume":"27","author":"Berthold","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nrd.2016.184","article-title":"Phase II and phase III failures: 2013-2015","volume":"15","author":"Harrison","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrd4090","article-title":"Trial watch: phase II and phase III attrition rates 2011-2012","volume":"12","author":"Arrowsmith","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"31ec76","DOI":"10.1126\/scitranslmed.3001254","article-title":"Phase 2B clinical trials\u2014a useful interim step to a phase 3 clinical trial","volume":"2","author":"Carlson","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/sim.3676","article-title":"Some design issues in phase 2B vs phase 3 prevention trials for testing efficacy of products or concepts","volume":"29","author":"Gilbert","year":"2010","journal-title":"Stat Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/annonc\/mdx795","article-title":"Phase I-II clinical trial design: a state-of-the-art paradigm for dose finding","volume":"29","author":"Yan","year":"2018","journal-title":"Ann Oncol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.51731\/cjht.2022.385","article-title":"Platform, basket, and umbrella trial designs: Issues around health technology assessment of novel therapeutics","volume":"2","author":"Tarride","year":"2022","journal-title":"Canadian Agency Drugs Technol Health"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"113278","DOI":"10.1016\/j.ejca.2023.113278","article-title":"Modified study designs to expand treatment options in personalised oncology: a multistakeholder view","volume":"194","author":"Le Tourneau","year":"2023","journal-title":"Eur J Cancer"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.21037\/atm-22-356","article-title":"Challenges, opportunities, and innovative statistical designs for precision oncology trials","volume":"10","author":"Yin","year":"2022","journal-title":"Ann Transl Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13073-022-01102-1","article-title":"Clinical trial design in the era of precision medicine","volume":"14","author":"Fountzilas","year":"2022","journal-title":"Genome Med"},{"year":"","key":"ref51"},{"year":"","key":"ref52"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1598789\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T05:33:59Z","timestamp":1753335239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1598789\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":52,"alternative-id":["10.3389\/fneur.2025.1598789"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1598789","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"article-number":"1598789"}}